Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the center ...
2-Year U.S. Treasury Note Continuous Contract $104.371-0.023-0.02% 5-Year U.S. Treasury Note Continuous Contract $109.141-0.023-0.02% 10-Year U.S. Treasury Note Continuous Contract $112.188-0.016-0.01 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback